Brief: Moberg Pharma Q1 EBITDA Loss Narrows To SEK 3.7 Mln
13/05/2025 07:07
May 13 (Reuters) - Moberg Pharma AB (publ) MBPH.ST: Q1 NET REVENUE SEK 3.9 MILLION (0.8) Q1 EBITDA SEK -3.7 MILLION WE ARE EVALUATING HOW INTERNAL RESOURCES ARE ALLOCATED TO ENSURE ALIGNMENT WITH OUR CURRENT PHASE OF COMMERCIALIZATION WE HAVE INITIATED REVIEW OF OUR STAFFING STRUCTURE AND IMPLEMENTED COST-SAVINGS MEASURES IN AREAS WITH LOWER ACTIVITY Source text: ID:nWkrHv7Q9 Further company coverage: MBPH.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))